CalciMedica (CALC) announced the appointment of Stephen Bardin as CFO and the planned departure of Daniel Geffken, Interim CFO upon filing the company’s third quarter financial statements. Bardin brings extensive capital raising, corporate development, and strategic finance expertise to CalciMedica, having most recently served as CFO of atai Life Sciences.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter